INO Stock Summary and Trading Ideas (Inovio Pharmaceuticals | NASDAQ:INO)

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Inovio Pharmaceuticals trades on the NASDAQ stock market under the symbol INO.

As of March 6, 2026, INO stock price climbed to $1.74 with 576,909 million shares trading.

INO has a beta of 1.34, meaning it tends to be more sensitive to market movements. INO has a correlation of 0.07 to the broad based SPY ETF.

INO has a market cap of $119.54 million. This is considered a Micro Cap stock.

Last quarter Inovio Pharmaceuticals reported $0 in Revenue and -$.44 earnings per share. This fell short of revenue expectation by $-8,330 and exceeded earnings estimates by $.05.

In the last 3 years, INO traded as high as $14.88 and as low as $1.30.

The top ETF exchange traded funds that INO belongs to (by Net Assets): VTI, VXF, IWC.

INO has underperformed the market in the last year with a return of -11.2%, while the SPY ETF gained +18.7%. In the last 3 month period, INO fell short of the market, returning -15.9%, while SPY returned -1.7%. However, in the most recent 2 weeks INO has outperformed the stock market by returning +0.6%, while SPY returned -2.5%.

INO support price is $1.61 and resistance is $1.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INO shares will trade within this expected range on the day.